Survival of living-related kidney graft recipients in the era of modern immunosuppressive treatment

BACKGROUND AND OBJECTIVES: Currently, there is no consensus about immunosuppressive therapy following kidney transplantation. Acute rejection rates and allograft survival rates are the clinical outcomes traditionally used to compare the efficacy of various immunosuppressive regimens. Therefore, we c...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamovic, Goran, Zerem, Enver, Osmanovic, Enes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119969/
https://www.ncbi.nlm.nih.gov/pubmed/21623058
http://dx.doi.org/10.4103/0256-4947.81546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119969/
https://www.ncbi.nlm.nih.gov/pubmed/21623058
http://dx.doi.org/10.4103/0256-4947.81546

Ejemplares similares